Evidence map›Paper›PMID 41719432›Full record

ArticleThe Journal of international medical research2026

Fertility preservation in women with endometriosis: How, when, and for whom?

Dimitrios Rafail Kalaitzopoulos, Alexandra Sabrina Kohl Schwartz

Abstract readEditorial
In one paragraph

Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dimitrios Rafail KalaitzopoulosDepartment of Obstetrics and Gynecology, Cantonal Hospital of Schaffhausen, Switzerland.ORCID 0000-0002-8053-1308
Alexandra Sabrina Kohl SchwartzDivision of Gynecological Endocrinology and Reproductive Medicine, Women's Hospital, Lucerne Cantonal Hospital, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fertility preservation options, including cryopreservation of oocytes, embryos, and ovarian tissue, were initially focused on women undergoing gonadotoxic chemotherapy for oncologic treatment. The indications have expanded to include nonmalignant conditions that can also lead to follicular loss. Endometriosis is a chronic inflammatory, estrogen-dependent entity with a prevalence of 25%-50% in infertile patients. A reduction in the ovarian reserve among women with endometriosis may result either from the disease itself or from its surgical treatment. The aim of this editorial was to identify patients with endometriosis who may benefit from fertility preservation and discuss the available evidence.

Indexed as

EndometriosisFertility PreservationInfertility, FemaleCryopreservationFemaleHumansOvarian ReserveOvaryanti-Müllerian hormoneEndometriosisfertility preservationovarian endometriomaovarian reserves

Identifiers

PMID41719432
PMCPMC12924948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.